News, Short Squeeze, Breakout and More Instantly...
2024-07-23 08:00:17 ET Leland Gershell from Oppenheimer issued a price target of $546.00 for ARGX on 2024-07-23 07:02:00. The adjusted price target was set to $546.00. At the time of the announcement, ARGX was trading at $461.01. The overall price target consensus is at ...
July 18, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, Ju...
First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study July 16, 2024 6:30am CET Amsterdam, the Netherlands— ...